Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

NAFLD in PCOS patients is linked to early kidney problems.

TGF-alpha affects skin thickness, hair growth, and may contribute to psoriasis and papilloma formation.

Mice with human-like EGFR had growth issues, skin defects, heart problems, and unusual bone development.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

EGFR is essential for normal hair development and follicle differentiation.

Understanding EGFR's role in skin is crucial for better treatments and managing side effects.

EGF controls hair growth by regulating hair follicles' growth phases.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Epidermal growth factor helps hair stem cells grow by activating specific cell pathways.

Cetuximab can cause excessive eyelash growth.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Overexpressing the epigen gene in mice leads to enlarged sebaceous glands and greasy fur.

Erlotinib can cause nonscarring hair loss and itchy skin.

Erlotinib may cause scarring hair loss.

Reduced EGFR signaling delays hair cycle and reduces fat growth, but hair development remains normal.

New cancer drugs often cause skin and nail problems.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Erlotinib can cause hair loss as a side effect.

Genetic changes in mice help understand skin and hair disorders, aiding treatment development for acne and hair loss.